Ursprung des Netzwerks ersten Grades von Jamie Holt
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Rojos Famous, Inc.
 Rojos Famous, Inc. Food: Specialty/CandyConsumer Non-Durables Rojos Famous, Inc. is a consumer packaged goods company that was founded in 2017. The company is based in the -area and has developed a breakfast pancake sandwich filled with eggs, breakfast meats, cheese, fruit, and plant-based meats. The company is based in Normandy Park, WA. Rojos Famous aims to provide a convenient, tasty, and natural ingredient pancake breakfast sandwich to consumers that is innovative and not a retread of traditional breakfast options. The company's mission is to provide healthy breakfast alternatives utilizing high-quality ingredients in both their original and plant-based pancake breakfast sandwiches. The company was founded in 2017 by John Marbett, Robert J. Selfridge. Robert J. Selfridge has been the CEO since 2017.
2
| Holding Company | Food: Specialty/Candy | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jamie Holt
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| GLOW HOLDINGS, INC. | Financial Conglomerates | Chief Executive Officer | |
| University of Idaho | College/University | Undergraduate Degree | |
Cedar River Foods LLC
 Cedar River Foods LLC Food: Major DiversifiedConsumer Non-Durables Part of Glow Holdings, Inc., Cedar River Foods LLC is a company that manufactures food products. The company is based in Gig Harbor, WA. The company was founded by Robert J. Selfridge. Cedar River Foods was acquired by Glow Holdings, Inc. on October 28, 2014 for $2.08 million. | Food: Major Diversified | Founder | |
Kalivir Immunotherapeutics, Inc.
 Kalivir Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kalivir Immunotherapeutics, Inc. is a privately held biotech company based in Pittsburgh, PA. The company is focused on developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs. Kalivir has developed a unique virus-based platform, enhanced template "vet" platform, that can generate potent novel oncolytic viruses with modifications to maximize viral replication and to enhance intravenous delivery and spread. The company has separate collaborations with Roche and Astellas Pharma to design and generate novel oncolytic viruses derived from the vet™ platform. Kalivir is currently advancing multiple therapeutic candidates toward the clinic. The CEO of the company is Helena H. Chaye. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 6 |
Sektoral
| Finance | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
| Consumer Non-Durables | 2 |
| Health Technology | 2 |
Operativ
| Founder | 3 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert J. Selfridge | 4 |
| Tom Leonard | 3 |
- Börse
- Insiders
- Jamie Holt
- Unternehmensverbindungen
